Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
RVMD
RVMD
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
RVMD News
Revolution Medicines Releases Updated Clinical Data for Zoldonrasib
20h ago
Newsfilter
Revolution Medicines Closes Upsized Offering of 12.1 Million Shares
2d ago
Newsfilter
Revolution Medicines Raises Approximately $1.5 Billion in Public Offering
5d ago
seekingalpha
Revolution Medicines Prices $2 Billion Upsized Public Offerings
5d ago
NASDAQ.COM
Revolution Medicines Prices Concurrent Public Offerings Raising $1.5 Billion
5d ago
Newsfilter
Revolution Medicines Raises $1.5 Billion in Public Offerings
5d ago
Yahoo Finance
Revolution's Cancer Drug Trial Shows Significant Survival Improvements
5d ago
stocktwits
Revolution Medicines Plans $1 Billion Financing
6d ago
NASDAQ.COM
Revolution Medicines Hits All-Time High on Trial Success
6d ago
Yahoo Finance
U.S. Stocks Close Higher, Led by Tech Sector Gains
6d ago
NASDAQ.COM
Mixed US Stock Performance Amid Soaring Oil Prices
6d ago
NASDAQ.COM
Oil Price Surge Triggers Market Volatility
6d ago
NASDAQ.COM
Revolution Medicines Plans to Raise $1 Billion Through Public Offerings
6d ago
seekingalpha
Revolution's Cancer Drug Shows Promising Results in Trials
6d ago
stocktwits
Stock Price Movements of Various Companies
6d ago
CNBC
Revolution Medicines Reports Positive Phase 3 Data for Daraxonrasib
Apr 13 2026
seekingalpha
Show More News